General Information of Drug Inactive Ingredient (DIG) (ID: E00336)

DIG Name
Butylated hydroxytoluene
Synonyms
2,6-Di-tert-butyl-4-methylphenol; Butylated hydroxytoluene; 128-37-0; Butylhydroxytoluene; 2,6-Di-tert-butyl-p-cresol; 2,6-Di-t-butyl-4-methylphenol; Ionol; BHT; DBPC; Dibunol; Stavox; Ionol CP; Phenol, 2,6-bis(1,1-dimethylethyl)-4-methyl-; Impruvol; Topanol; Dalpac; Deenax; Ionole; Vianol; Antioxidant KB; 3,5-Di-tert-butyl-4-hydroxytoluene; Antioxidant 4K; Sumilizer BHT; Topanol O; Topanol OC; Vanlube PC; Antioxidant DBPC; Sustane BHT; Tenamene 3; Vanlube PCX; Antioxidant 29; Antioxidant 30; Nonox TBC; Tenox BHT; Di-tert-butyl-p-cresol; Chemanox 11; 2,6-ditert-butyl-4-methylphenol; Ionol 1; Agidol; Catalin CAO-3; Advastab 401; Ionol (antioxidant); BUKS; Parabar 441; Paranox 441; 2,6-Di-tert-butyl-4-cresol; Catalin antioxydant 1; Antrancine 8; Butylated hydroxytoluol; Vulkanox KB; Dibutylated hydroxytoluene; Ional; 2,6-Bis(1,1-dimethylethyl)-4-methylphenol; AO 4K; CAO 1; CAO 3; Di-tert-butyl-p-methylphenol; o-Di-tert-butyl-p-methylphenol; 4-Methyl-2,6-tert-butylphenol; 2,6-Di-tert-butyl-1-hydroxy-4-methylbenzene; 2,6-Di-tert-butyl-p-methylphenol; AO 29; NCI-C03598; 2,6-DI-T-BUTYL-P-CRESOL; 4-Methyl-2,6-di-tert-butylphenol; Butyl hydroxy toluene; 2,6-Di-terc.butyl-p-kresol; 4-Hydroxy-3,5-di-tert-butyltoluene; MFCD00011644; FEMA No. 2184; P 21; Bht(food grade); 4-Methyl-2,6-di-terc. butylfenol; 1-Hydroxy-4-methyl-2,6-di-tert-butylbenzene; Di-tert-butylcresol; UNII-1P9D0Z171K; Butylated hydroxytoluene (bht); Dbpc(technical grade); E321; p-Cresol, 2,6-di-tert-butyl-; 2,6-ditert-butyl-4-methyl-phenol; 2,6-Di-tert-butyl-4-methyl-phenol; CHEMBL146; CHEBI:34247; 1P9D0Z171K; NSC-6347; 2,6-di-tert-butyl-4-methyl phenol; 2,6-bis(tert-butyl)-4-methylphenol; NCGC00091761-03; Kerabit; Tonarol; 2,6-Di-tert-butyl-4-methylphenol, 99%; DSSTox_CID_216; Antioxidant MPJ; Antioxidant 4; Toxolan P; Alkofen BP; Swanox BHT; Tenamen 3; Antox QT; Antioxidant 264; DSSTox_RID_75440; Agidol 1; DSSTox_GSID_20216; Bht (food grade); Antioxidant T 501; Nocrac 200; Caswell No. 291A; Dbpc (technical grade); Annulex BHT; AOX 4K; AOX 4; CAS-128-37-0; Butylohydroksytoluenu; CCRIS 103; Butylohydroksytoluenu [Polish]; Ionol CP-antioxidant; 1,3-Dioxolane, 99.5+%, pure, stabilized; 2,6-Di-tert-butyl-4-methylphenol, 99.8%; Di-tert-butyl-p-cresol (VAN); HSDB 1147; BHT 264; NSC 6347; EINECS 204-881-4; 2,6-Di-terc.butyl-p-kresol [Czech]; EPA Pesticide Chemical Code 022105; Dibutylcresol; 2,6-Di-tert-butyl-4-methylhydroxybenzene; Popol; AI3-19683; 4-Methyl-2,6-di-terc. butylfenol [Czech]; Lowinox BHT; Nipanox BHT; 1,3-Dioxolane, 99.8%, anhydrous, stabilized with 75 ppm BHT, AcroSeal(R); BHT Swanox; BHT, food grade; 4-Methyl-2,6-di-t-butyl-phenol; Butylhydroxytoluenum; Ionol BHT; Ralox BHT; 2, food grade; Butylated hydroxytoluene [BAN:NF]; Dibutyl-para-cresol; butylated-hydroxytoluene; PubChem20842; Spectrum_001790; ACMC-1BUTL; SpecPlus_000768; Methyldi-tert-butylphenol; Spectrum3_001849; Spectrum5_001612; Hydagen DEO (Salt/Mix); EC 204-881-4; 2,6-di-Butyl-para-cresol; 2.6-di-t-butyl-p-cresol; SCHEMBL3950; 2,6-ditert-butyl-p-cresol; p-Cresol,6-di-tert-butyl-; Di-tert-Butylparamethylphenol; BSPBio_003238; KBioSS_002281; 2,6-di-tert.butyl-p-cresol; Di-tert-Butyl-4-methylphenol; MLS000069425; BIDD:ER0031; Butylated hydroxytoluene (NF); DivK1c_006864; SPECTRUM1600716; 2,6-bis-tert-butyl-p-cresol; 2,6-di-tert-butyl-paracresol; BHT (butylated hydroxytoluene); 2,6-di-tert. butyl-p-cresol; 2,6-di-tert.-butyl-p-cresol; INS NO.321; 2,6-di-tert-butyl-para-cresol; 2,6-di-tert-Butyl-methylphenol; 2,6-ditertbutyl-4-methylphenol; DTXSID2020216; 2,6-di-t butyl-4-methylphenol; 2.6-di-t-butyl-4-methylphenol; FEMA 2184; KBio1_001808; KBio2_002280; KBio2_004848; KBio2_007416; KBio3_002738; 2,6-di-tert-butyl-4-methylenol; 2,6-di-tert-butyl-4methylphenol; 2,6-di-tert-butyl4-methylphenol; 2,6-di-tertbutyl-4-methylphenol; 2,6-ditert.butyl-4-methylphenol; Butylated hydroxyl toluene (BHT); INS-321; NSC6347; 2,6-Di(tert-butyl)hydroxytoluene; 2,6-di(t-butyl)-4-methylphenol; 2,6-di-t- butyl-4-methylphenol; 2,6-di-t-butyl 4-methyl phenol; 2,6-di-t-butyl-4-methyl phenol; 2,6-di-t-butyl-4-methyl-phenol; 3,5-di-t-butyl-4-hydroxytoluene; HMS2091E21; HMS2231M22; HMS3369G17; HMS3750M21; Pharmakon1600-01600716; 2,1-dimethylethyl)-4-methylphenol; 2,6-di-tert-butyl 4-methylphenol; 2,6-di-tert-butyl-4 methylphenol; 2,6-di-tert-butyl4-methyl phenol; 2,6-di-tert.butyl-4-methylphenol; 2,6-ditert.-butyl-4-methylphenol; 2.6-di-tert-butyl-4-methylphenol; 4-methyl-2,6-di-tert.butylphenol; 2,6-di-ter-butyl-4-methyl-phenol; 2,6-Di-tert.-Butyl4-methylphenol; 2,6-ditertiarybutyl-4-methylphenol; 2.6-di- t-butyl- 4-methylphenol; AMY40200; HY-Y0172; STR04334; ZINC1481993; 2,6 -di-tert-butyl-4-methylphenol; 2,6-di(tert-butyl)-4-methylphenol; 2,6-Di-tert-butyl-p-cresol, 8CI; 2,6-di-tert.-butyl-4-methylphenol; Tox21_113537; Tox21_201093; Tox21_303408; 2,6-di-tert-butyl-p-cresol (BHT); 2,6-Di-tert-butyl-para-methylphenol; ANW-19063; BDBM50079507; NSC759563; s6202; SBB040854; STL277184; 2,6-di-tert. butyl-4-methyl phenol; 2,6-Di-(tert-butyl)-4-methylphenol; AKOS000269037; Tox21_113537_1; CCG-207937; CM14391; CS-W020053; MCULE-4627478482; NSC-759563; Phenol, 2,6-di-tert-butyl-4-methyl-; NCGC00091761-01; NCGC00091761-02; NCGC00091761-04; NCGC00091761-05; NCGC00091761-06; NCGC00091761-07; NCGC00257275-01; NCGC00258645-01; AC-10553; AK-90086; L133; SMR000059076; 2,6-Di-tert-butyl-4-methylphenol (BHT); SBI-0052890.P002; 2,6-Di-tert-butyl-4-methylphenol, >=99%; Butylated hydroxytoluene, >=99%, FCC, FG; D0228; E-321; FT-0610731; Phenol,6-bis(1,1-dimethylethyl)-4-methyl-; ST50214443; 2,6-bis-(1,1-dimethylethyl)-4-methylphenol; 4-Methyl-2,6- di(1,1-dimethylethyl)phenol; PK04_181024; 2,6-Di-tert-butyl-1-hydroxy-4-methyl benzene; C14693; D02413; M-6087; MLS-0146297.0001; AB00053233_09; Phenol, 3,5-bis(1,1-dimethylethyl)-4-methyl-; 2,6-Bis(1,1-dimethylethyl)-4-methylphenol, 9CI; 2,6-Di-tert-butyl-4-methylphenol, puriss., 99%; AC-907/25014329; Q221945; SR-01000735918; SR-01000735918-2; W-108376; 9FC4DFC8-480D-487C-A74A-2EC9EECE92C4; BENZENE,1,3-DITERT.BUTYL,2-HYDROXY,5-METHYL; BRD-K53153417-001-01-3; BRD-K53153417-001-06-2; 2,6-D[(CH3)3C]2C6H2(CH3)OHi-tert-butyl-p-cresol; F0001-0395; Z955123624; 2,6-DI(TERT-BUTYL-D9)-4-METHYLPHENOL-3,5,O-D3; 2,6-Di-tert-butyl-4-methylphenol, purum, >=99.0% (GC); WLN: 1X1 & 1 & R BQ E1 CX1 & 1 & 1; 2,6-Di-tert-butyl-4-methylphenol, >=99.0% (GC), powder; 2,6-Di-tert-butyl-4-methylphenol, SAJ first grade, >=99.0%; 2,6-Di-tert-butyl-4-methylphenol, tested according to Ph.Eur.; 3,5-Di-tert-4-butylhydroxytoluene (BHT), analytical standard; 2,6-Di-tert-butyl-4-methylphenol 1000 microg/mL in Acetonitrile; Butylhydroxytoluene, European Pharmacopoeia (EP) Reference Standard; 2,6-Di-tert-butyl-4-methylphenol, certified reference material, TraceCERT(R); Butylated Hydroxytoluene, Pharmaceutical Secondary Standard; Certified Reference Material; Butylated hydroxytoluene, United States Pharmacopeia (USP) Reference Standard
DIG Function
Antioxidant
Formula
C15H24O
Canonical SMILES
CC1=CC(=C(C(=C1)C(C)(C)C)O)C(C)(C)C
InChI
1S/C15H24O/c1-10-8-11(14(2,3)4)13(16)12(9-10)15(5,6)7/h8-9,16H,1-7H3
InChIKey
NLZUEZXRPGMBCV-UHFFFAOYSA-N
Physicochemical Properties Molecular Weight 220.35 Topological Polar Surface Area 20.2
XlogP 5.3 Complexity 207
Heavy Atom Count 16 Rotatable Bond Count 2
Hydrogen Bond Donor Count 1 Hydrogen Bond Acceptor Count 1

Full List of Drug(s) Co-administrated with This DIG

40 Approved Drug(s) Co-administrated with This DIG
Drug Name Drug ID Indication Formulation Name Formulation ID
Abametapir DM2RX0I Head and body lice [1G00.0] Abametapir 0.74% lotion F23062
Amlodipine DMBDAZV Angina pectoris [BA40] Amlodipine 10 mg tablet F01144
Aspirin DM672AH Acute coronary syndrome [BA41] Aspirin 81 mg tablet F01657
Calcidiol DMN4CV5 Hypophosphatemia [] Calcifediol 0.03 mg capsule F03145
Calcitriol DM8ZVJ7 Congenital alopecia [LC30] Calcitriol 0.0005 mg capsule F03161
Cetirizine DMOMP9U Allergic rhinitis [CA08.0] Cetirizine 10 mg capsule F03877
Clofazimine DMEBOFW Crohn disease [DD70] Clofazimine 100mg capsule F23118
crisaborole DMNVKU6 Atopic dermatitis [EA80] Crisaborole 2% ointment F24258
Deutetrabenazine DMUPFLI Huntington disease [8A01.10] Deutetrabenazine 12 mg tablet F05457
Dutasteride DMQ4TJK Benign prostatic hyperplasia [GA90] Dutasteride 0.5 mg capsule F07170
Efinaconazole DMFA9MV Fungal infection [1F29-1F2F] Efinaconazole 10% solution F23148
Enzalutamide DMGL19D Prostate cancer [2C82.0] Enzalutamide 40mg capsule F23734
Escitalopram DMFK9HG Major depressive disorder [6A70.3] Escitalopram 10 mg tablet F07392
Everolimus DM8X2EH Advanced cancer [2A00-2F9Z] Everolimus 2 mg tablet F07808
Exemestane DM9HPW3 Hormonally-responsive breast cancer [2C60-2C65] Exemestane 25 mg tablet F07814
Felodipine DMOSW35 Hypertension [BA00-BA04] Felodipine 5 mg tablet F07929
Fidaxomicin DMFP6MV Clostridioides difficile infection [1A04] Fidaxomicin 200 mg tablet F08213
Glipizide DMZA5PQ Diabetic complication [5A2Y] Glipizide 5 mg tablet F09259
Halcinonide DMGLAX1 Exanthem [] Halcinonide 0.1% solution F23764
Hydrocodone DMQ2JO5 Allergic rhinitis [CA08.0] Hydrocodone 20 mg tablet F09770
Hydromorphone DMHP21E Back pain [ME84.Z] Hydromorphone 12 mg tablet F09818
Luliconazole DMT73J8 Tinea corporis [1F28.Y] Luliconazole 1% cream F23217
Methylphenidate DM7SJD6 Attention deficit hyperactivity disorder [6A05.Z] Methylphenidate 27 mg tablet F13592
Metoclopramide DMFA5MY Nausea [MD90] Metoclopramide 10 mg tablet F13659
Mirabegron DMS1GYT Overactive bladder [GC50.0] Mirabegron 25mg extended release tablet F23822
Morphine DMRMS0L Advanced cancer [2A00-2F9Z] Morphine 200 mg tablet F14562
Oxycodone DMXLKHV Osteoarthritis [FA00-FA05] Oxycodone 80 mg tablet F16381
Oxymetazoline DM8ZXT6 Arrhythmia [BC9Z] Oxymetazoline 1% cream F23856
Paliperidone DM7NPJS Psychotic disorder [6A20-6A25] Paliperidone 9 mg tablet F16471
Paricalcitol DMYBV3G Hyperparathyroidism [5A51] Paricalcitol 0.002 mg capsule F16586
Permethrin DMZ0Q1G Pediculus capitis infestation [1G00.0] Permethrin 5% cream F23868
Prednisolone DMQ8FR2 Acute adrenal insufficiency [] Prednisolone 20 mg tablet F17746
Raltegravir DMYURI6 Human immunodeficiency virus infection [1C62] Raltegravir 400 mg tablet F18693
Ritonavir DMU764S Human immunodeficiency virus infection [1C62] Ritonavir 100 mg capsule F19273
Rosuvastatin DMMIQ7G Arteriosclerosis [BD40] Rosuvastatin 20 mg tablet F19633
Sertraline DM0FB1J Coronary heart disease [BA80.Z] Sertraline 100 mg tablet F19767
Sulfacetamide DMZ6VEY Acne vulgaris [ED80] Sulfacetamide 10% solution F23908
Tacrolimus DMZ7XNQ Graft-versus-host disease [4B24] Tacrolimus 0.75 mg tablet F20587
Verapamil DMA7PEW Angina pectoris [BA40] Verapamil 180 mg tablet F22380
Zithromax DMN4H2O Syphilis infection [1A6Z] Azithromycin 250 mg tablet F02144
------------------
⏷ Show the Full List of 40 Approved Drug(s)
1 Investigative Drug(s) Co-administrated with This DIG
Drug Name Drug ID Indication Formulation Name Formulation ID
Oxybutynine DMJPBAX Obsolete neurogenic bladder [] Oxybutynin 10 mg tablet F16171
------------------